Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

NCT02801617 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

116

Enrollment

INDUSTRY

Sponsor class

Stopped expiration time limit of recruitment

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: PRO-067
DRUG: GAAP Ofteno®

Sponsor

Laboratorios Sophia S.A de C.V.